Emerging onto the horizon, Retatrutide is creating considerable interest within the medical field . This innovative medication, a dual GIP and GLP-1 agonist, demonstrates promising outcomes in clinical trials . Early findings suggest it appears to offer a substantial degree of body mass reduction